Role of Vascular Endothelial Growth Factor (VEGF) and doppler sub-endometrial parameters as predictors of successful implantation in Intracytoplasmic Sperm Injection (ICSI) patients

Objective: to investigate the expression of vascular endothelial growth factor (VEGF) in patients having infertility due to low endometrial acceptance, and to correlate it to non-invasive ultrasound variables, endometrial thickness, and sub-endometrial Doppler parameters (PI, RI, Vs/Vd). Methods: 80 women all under the age of 40 underwent ICSI-ET; all patients were exposed to ovarian stimulation protocols. The oocytes were retrieved using an ultrasound guide, and were fertilised via injection of sperm inside the follicle (ICSI). VEGF serum level was analysed at day of embryo transfer by ELIZA test, and sub-endometrial evaluation was conducted via two-dimension power Doppler ultrasound (2D PD-US), by measuring resistance index (RI) and pulsatility index (PI) on the day of embryo transfer. Results: There was a significantly higher VEGF level and endometrial thickness in pregnant (433± 207 and 9.72± 1.35) women, compared to non-pregnant (276± 165 and 8.95 ± 1.21) respectively as p-values were (0.001 and 0.01)). Additionally, there were significantly lower RI and PI in pregnant (0.584 ± 0.124 and 0.829 ± 0.301) women compared to non-pregnant (0.651±0.132 and 1.006±0.335) women, as p-values were (0.02 and 0.02, respectively). The level of E2 was on the day of embryo transfer and Vs/Vd in pregnant women (1402± 524 and 3.14 ± 3.75) and in the non-pregnant group (1296± 611 and 3.82 ± 3.07), as p-values were 0.41 and 0.38, respectively. Conclusion: The combined analysis of endometrial receptivity was completed, and the serum level of VEGF and sub-endometrial evaluation with 2D PD-US was defined by measuring resistance index (RI) and pulsatility index (PI) on the day of embryo transfer. These can serve as useful prognostic methods for the detection of endometrial receptivity and pregnancy outcomes in infertile women undergoing ICSI protocols, and will be helpful for candidate counselling about postponing embryo transfer and cryopreservation, which may serve as a better option, to be recommended for the next cycle, when achieving better endometrial Doppler parameters

Design and Fabrication of Small Vertical-Take-Off-Landing Unmanned Aerial Vehicle

Modern UAVs available in the market have well-developed to cater to the countless field of application. UAVs have their own limitations in terms of flight range and manoeuvrability. The traditional fixed-wing UAVs can fly for long distance but require runways or wide-open spaces for take-off and landing. On the other hand, the more trending multirotor UAVs are extremely manoeuvrable but cannot be used for long-distance flights because of their slower speeds and relatively higher consumption of energy. This study proposed the implementation of hybrid VTOL UAV which has the manoeuvring advantage of a multirotor UAV while having the ability to travel fast to reach a further distance. The design methodology and fabrication method are discussed extensively which would be followed by a number of flight tests to prove the concept. The proposed UAV would be equipped with quadcopter motors and a horizontal thrust motor for vertical and horizontal flight modes respectively

Response surface methodology for predicting the dimethylphenol removal from wastewater via reverse osmosis process

YesReverse Osmosis (RO) process can be considered as one of the intensively used pioneering equipment for reusing wastewater of several applications. The recent study presented the development of an accurate model for predicting the dimethylphenol removal from wastewater via RO process. The Response Surface Methodology (RSM) was applied to carry out this challenge based on actual experimental data collected from the literature. The independent variables considered are the inlet pressure (5.83-13.58) atm, inlet temperature (29.5-32) ° C, inlet feed flow rate (2.166-2.583) × 10-4 m3/s, and inlet concentration (0.854-8.049) × 10-3 kmol/m3 and the dimethylphenol removal is considered as the response variable. The analysis of variance showed that the inlet temperature and feed flow rate have a negative influence on dimethylphenol removal from wastewater while the inlet pressure and concentration show a positive influence. In this regard, F-value of 240.38 indicates a considerable contribution of the predicted variables of pressure and concentration against the process dimethylphenol rejection. Also, the predicted R2 value of 0.9772 shows the high accuracy of the model. An overall assessment of simulating the performance of RO process against the operating parameters has been systematically demonstrated using the proposed RSM model

Hydrogen rich gas from oil palm biomass as a potential source of renewable energy in Malaysia

Oil palm is one of the major economic crops in many countries. Malaysia alone produces about 47% of the world's palm oil supply and can be considered as the world's largest producer and exporter of palm oil. Malaysia also generates huge quantity of oil palm biomass including oil palm trunks, oil palm fronds, empty fruit bunches (EFB), shells and fibers as waste from palm oil fruit harvest and oil extraction processing. At present there is a continuously increasing interest in the utilization of oil palm biomass as a source of clean energy. One of the major interests is hydrogen from oil palm biomass. Hydrogen from biomass is a clean and efficient energy source and is expected to take a significant role in future energy demand due to the raw material availability. This paper presents a review which focuses on different types of thermo-chemical processes for conversion of oil palm biomass to hydrogen rich gas. This paper offers a concise and up-to-date scenario of the present status of oil palm industry in contributing towards sustainable and renewable energy

Prevalence of anti-BK polyomavirus IgG in A Sample of Iraqi renal transplant recipients

Background: BK virus, a human polyomavirus, causes nephropathy and allograft loss in renal transplant recipients. Although it was discovered in 1971, understanding of the humoral immune response to BKV is limited. Objective: To serological detection and level estimation of anti-BK-IgG in renal-transplanted recipients and healthy blood donors as control. Patients and Methods: Serum samples were collected from 106 renal transplant recipient patients and 100 healthy  blood donors as control groups, and were analyzed for anti-BK IgG antibodies by using quantitative and qualitative Human BK Virus IgG (BK-IgG) ELISA kit for detection and estimation positivity of BK_IgG and titration. Results: Out of 206 subjects, 114(55.3%) have a positive result for BK-IgG. seropositivity was detected in 54(50.9%) of 106 RTR patients and 60 (60.0%) in the 100 control group, so there was no significant difference between seropositivity of BKV IgG antibody among the studied groups, p =0.191. Conclusion: The highly significant differences between seropositivity of BK-IgG with high levels of serum creatinine

The Changing Landscape for Stroke\ua0Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

Background GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non\u2013vitamin K antagonist oral anticoagulant (NOAC), became available. Objectives This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1. Methods During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis describes eligible patients\u2019 baseline characteristics. Atrial fibrillation disease characteristics, medical outcomes, and concomitant diseases and medications were collected. Data were analyzed using descriptive statistics. Results Of the total patients, 45.5% were female; median age was 71 (interquartile range: 64, 78) years. Patients were from Europe (47.1%), North America (22.5%), Asia (20.3%), Latin America (6.0%), and the Middle East/Africa (4.0%). Most had high stroke risk (CHA2DS2-VASc [Congestive heart failure, Hypertension, Age  6575 years, Diabetes mellitus, previous Stroke, Vascular disease, Age 65 to 74 years, Sex category] score  652; 86.1%); 13.9% had moderate risk (CHA2DS2-VASc = 1). Overall, 79.9% received oral anticoagulants, of whom 47.6% received NOAC and 32.3% vitamin K antagonists (VKA); 12.1% received antiplatelet agents; 7.8% received no antithrombotic treatment. For comparison, the proportion of phase 1 patients (of N = 1,063 all eligible) prescribed VKA was 32.8%, acetylsalicylic acid 41.7%, and no therapy 20.2%. In Europe in phase 2, treatment with NOAC was more common than VKA (52.3% and 37.8%, respectively); 6.0% of patients received antiplatelet treatment; and 3.8% received no antithrombotic treatment. In North America, 52.1%, 26.2%, and 14.0% of patients received NOAC, VKA, and antiplatelet drugs, respectively; 7.5% received no antithrombotic treatment. NOAC use was less common in Asia (27.7%), where 27.5% of patients received VKA, 25.0% antiplatelet drugs, and 19.8% no antithrombotic treatment. Conclusions The baseline data from GLORIA-AF phase 2 demonstrate that in newly diagnosed nonvalvular atrial fibrillation patients, NOAC have been highly adopted into practice, becoming more frequently prescribed than VKA in Europe and North America. Worldwide, however, a large proportion of patients remain undertreated, particularly in Asia and North America. (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients With Atrial Fibrillation [GLORIA-AF]; NCT01468701

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

SummaryBackground Azithromycin has been proposed as a treatment for COVID-19 on the basis of its immunomodulatoryactions. We aimed to evaluate the safety and efficacy of azithromycin in patients admitted to hospital with COVID-19.Methods In this randomised, controlled, open-label, adaptive platform trial (Randomised Evaluation of COVID-19Therapy [RECOVERY]), several possible treatments were compared with usual care in patients admitted to hospitalwith COVID-19 in the UK. The trial is underway at 176 hospitals in the UK. Eligible and consenting patients wererandomly allocated to either usual standard of care alone or usual standard of care plus azithromycin 500 mg once perday by mouth or intravenously for 10 days or until discharge (or allocation to one of the other RECOVERY treatmentgroups). Patients were assigned via web-based simple (unstratified) randomisation with allocation concealment andwere twice as likely to be randomly assigned to usual care than to any of the active treatment groups. Participants andlocal study staff were not masked to the allocated treatment, but all others involved in the trial were masked to theoutcome data during the trial. The primary outcome was 28-day all-cause mortality, assessed in the intention-to-treatpopulation. The trial is registered with ISRCTN, 50189673, and ClinicalTrials.gov, NCT04381936.Findings Between April 7 and Nov 27, 2020, of 16 442 patients enrolled in the RECOVERY trial, 9433 (57%) wereeligible and 7763 were included in the assessment of azithromycin. The mean age of these study participants was65·3 years (SD 15·7) and approximately a third were women (2944 [38%] of 7763). 2582 patients were randomlyallocated to receive azithromycin and 5181 patients were randomly allocated to usual care alone. Overall,561 (22%) patients allocated to azithromycin and 1162 (22%) patients allocated to usual care died within 28 days(rate ratio 0·97, 95% CI 0·87–1·07; p=0·50). No significant difference was seen in duration of hospital stay (median10 days [IQR 5 to >28] vs 11 days [5 to >28]) or the proportion of patients discharged from hospital alive within 28 days(rate ratio 1·04, 95% CI 0·98–1·10; p=0·19). Among those not on invasive mechanical ventilation at baseline, nosignificant difference was seen in the proportion meeting the composite endpoint of invasive mechanical ventilationor death (risk ratio 0·95, 95% CI 0·87–1·03; p=0·24).Interpretation In patients admitted to hospital with COVID-19, azithromycin did not improve survival or otherprespecified clinical outcomes. Azithromycin use in patients admitted to hospital with COVID-19 should be restrictedto patients in whom there is a clear antimicrobial indication

Malignant Peritoneal Mesothelioma: A Rare Cause of Ascites

Malignant peritoneal mesothelioma (MPM) is a rare diagnosis that presents with difficulties in diagnosis and management. This article reports a case of an 88-year-old male who presented with a 2-week history of abdominal distention and bloating. He worked at an insulation production factory between the ages of 23 and 25 years with presumed asbestos exposure. On the computed tomography scan of the abdomen/pelvis, the patient was found to have diffuse omental, peritoneal, and mesenteric nodularity with moderate to large ascites. Omental biopsy revealed MPM. The overall prognosis of MPM remains poor, with a median survival time of 12 months at the time of diagnosis. Treatment modalities offered in the United States include chemotherapy alone, cytoreductive surgery alone, or cytoreductive surgery/chemotherapy combination

Modelling the chlorophenol removal from wastewater via reverse osmosis process using a multilayer artificial neural network with genetic algorithm

YesReverse Osmosis (RO) can be considered as one of the most widely used technologies used to abate the existence of highly toxic compounds from wastewater. In this paper, a multilayer artificial neural network (MLANN) with Genetic Algorithm (GA) have been considered to build a comprehensive mathematical model, which can be used to predict the performance of an individual RO process in term of chlorophenol removal from wastewater. The MLANN model has been validated against 70 observational experimental datasets collected from the open literature. The MLANN model predictions have outperformed the predictions of several structures developed for the same chlorophenol removal using RO process based on performance in terms of coefficient of correlation, coefficient determination (R2) and average error (AVE). In this respect, two structures (4-2-2-1) and (4-8-8-1) were also used to study the effect of a number of neurons in the hidden layers based on the difference between the measured and ANN predicted values. The model responses clearly confirm the successfulness of estimating the chlorophenol rejection for network structure 4-8-8-1 based on a wide range of the control variables. This also represents a high consistency between the ANN model predictions and the experimental data

Design and Fabrication of Small Vertical-Take-Off-Landing Unmanned Aerial Vehicle

Modern UAVs available in the market have well-developed to cater to the countless field of application. UAVs have their own limitations in terms of flight range and manoeuvrability. The traditional fixed-wing UAVs can fly for long distance but require runways or wide-open spaces for take-off and landing. On the other hand, the more trending multirotor UAVs are extremely manoeuvrable but cannot be used for long-distance flights because of their slower speeds and relatively higher consumption of energy. This study proposed the implementation of hybrid VTOL UAV which has the manoeuvring advantage of a multirotor UAV while having the ability to travel fast to reach a further distance. The design methodology and fabrication method are discussed extensively which would be followed by a number of flight tests to prove the concept. The proposed UAV would be equipped with quadcopter motors and a horizontal thrust motor for vertical and horizontal flight modes respectively.</p